Santa Ana Bio, Inc.
Alameda, CA · Founded 2020 · CIK 0001864492 · Biotech · Private
Targeted immunology therapeutics for autoimmune and inflammatory disease
santaana.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $63M
- 3 Form D · Jun 2024
- 28 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $8,024,658 | |
| Private capital raised | Form D · SEC | $35,313,642 | |
| Private capital raised | Form D · SEC | $19,999,998 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2890 | Network Music Partners, LLC | — | $205K |
| 2891 | Sage Therapeutics | — | $698M |
| 2892 | OTHRO THERAPEUTICS, INC. | — | — |
| 2893 | Santa Ana Bio, Inc. | — | $63M |
| 2894 | General Specific Inc. | — | $1.5M |
| 2895 | Character Biosciences, Inc. | — | $57M |
| 2896 | ANAPTYSBIO INC | — | $51M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Marcelo BigaloDirector
- Christine BorowskiDirector
- Brendan Bulik-SullivanDirector
- Jerel DavisDirector · Executive Officer
- Mittie DoyleDirector
- Peter EmtageDirector · Executive Officer
- Shinichiro FuseDirector
- Thomas WoiwodeDirector
Patents
- Antibodies Targeting C-kit And/or Siglec And Uses Thereofapplication
- Methods And Compositions For Treating Autoimmune, Allergic And Inflammatory Diseasesapplication
- Methods And Compositions For Treating Autoimmune, Allergic And Inflammatory Diseasesapplication
- Antibodies Targeting C-kit And/or Siglec And Uses Thereofapplication
- Antibodies Targeting FCER1, C-kit, And/or Siglec And Use Thereofapplication
- Methods And Compositions For Treating Autoimmune, Allergic And Inflammatory Diseasesapplication
- Methods And Compositions For Treating Autoimmune, Allergic And Inflammatory Diseasesapplication
- Methods And Compositions For Treating Autoimmune, Allergic And Inflammatory Diseasesapplication
- Antibodies Targeting FCER1, C-kit, And/or Siglec And Use Thereofapplication
- Methods And Compositions For Treating Autoimmune, Allergic And Inflammatory Diseasesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.